Search Results

62 results

  1. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 25

    Misperception of e-cigarette harm growing among American adults, 2013-2015

    VERRON T.(1); GUO M.(1); VARIGNON B.(1); O'CONNELL G.(2); WALELE T.(2); CAHOURS X.(1)
    (1) SEITA - Imperial Brands plc, Paris, France; (2) Fontem Ventures B.V., Amsterdam, The Netherlands
    Electronic cigarettes (e cigarettes) have been characterised as significantly less harmful than smoked tobacco by an increasing number of public health authorities. However, the proportion of American adults who perceive e cigarettes to be equally or more ...
  2. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 52 (also presented at TSRC 2018)also presented at TSRC 2018)

    Consumers’ perceptions of disease-specific modified-risk claims are best evaluated in a disease-specific manner

    SHIFFMAN S.(1); CURTIN G.(2)
    (1) Pinney Associates, Pittsburgh, PA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.
    Manufacturers seeking to make claims about modified-risk tobacco products (MRTPs) must assess consumers' perceptions of risk reduction for these products. Claims made for the MRTP and assessment of perceived risk reduction can be global (e.g. &quot ...
  3. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 53 (also presented at TSRC 2018)

    Comparing direct and indirect assessments of perceptions of reduced risk for a modified-risk tobacco product

    SHIFFMAN S.(1); CURTIN G.(2)
    (1) Pinney Associates, Pittsburgh, PA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.
    Manufacturers seeking to make claims about modified-risk tobacco products (MRTPs) must assess consumers' perceptions of absolute and relative risks for these products. We cross-validate data from two methods: (a) indirect assessments based on the ...
  4. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 52

    Biological test procedure for fresh generated cigarette smoke and e-cigarette aerosols under air-liquid interface (ALI) exposure in 24 and 96 multi-well plates

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    Cigarette smoke and e cigarette aerosol contain particulate matter/liquid droplets in the solid phase as well as volatile substances in the gas phase. Both fractions are of potential toxicological relevance and should be considered when assessing ...
  5. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 53

    Use of human derived cell lines to increase the biological relevance of cigarette condensate, non-tobacco materials and e-liquids testing

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    The in vitro testing strategy of tobacco products is mainly based on the testing of extracts from cigarette smoke condensates. An accepted industry wide assay battery has been developed over recent years which delivers reliable results for the ...
  6. TSRC, Tob. Sci. Res. Conf., 2018, 72, abstr. 030

    Comparisons of dependence on cigarettes and e-cigarettes: data from the path study

    KIM M.M.(1); SHIFFMAN S.(2); SEMBOWER M.(2)
    (1) RAI Services Company, Winston-Salem, NC, USA; (2) PinneyAssociates, Inc., Pittsburgh, PA, USA
    An Item-Response-Theory-based dependence scale, developed on PATH data, assesses e-cigarette dependence, and for the first time allows for direct comparison of dependence across products. Data were from adult established users of e-cigarettes (ECIG) and ...
  7. TSRC, Tob. Sci. Res. Conf., 2018, 72, abstr. 031

    Use patterns and tobacco use histories among users of diverse vapor products: cigalikes, tanks, and other vapor products

    KIM M.M.(1); SHIFFMAN S.(2); SEMBOWER M.(2)
    (1) RAI Services Company, Winston-Salem, NC, USA; (2) PinneyAssociates, Inc., Pittsburgh, PA, USA
    There are several types of vapor products, but little research has characterized differences in their use or users. We examined the differences in use and characteristics of users of cigalikes, tanks, and other, 'variant' vapor products in a ...
  8. TSRC, Tob. Sci. Res. Conf., 2018, 72, abstr. 036

    Trends in US smokers' perceptions of the relative risks of non-combustible tobacco products versus cigarettes

    CURTIN G.M.(1); SHIFFMAN S.(2); ROHAY J.(2); PYPE S.(2)
    (1) RAI Services Company, Winston-Salem, NC, USA; (2) PinneyAssociates, Inc., Pittsburgh, PA, USA
    Smokers can benefit from switching to less harmful tobacco products, which requires knowledge of relative product risk. However, publicly shared information often emphasizes absolute rather than relative risks. To understand smokers’ perceptions of ...
  9. TSRC, Tob. Sci. Res. Conf., 2018, 72, abstr. 038 (also presented at CORESTA 2018)

    Comparing direct and indirect assessments of perceptions of reduced risk for a modified-risk tobacco product

    SHIFFMAN S.(1); CURTIN G.M.(2)
    (1) PinneyAssociates, Pittsburgh, PA, USA; (2) RAI Services Company, Winston-Salem, NC, USA
    Manufacturers seeking to make claims about modified-risk tobacco products (MRTPs) must assess consumers' perceptions of absolute and relative risks for that product. We cross-validate data from two methods: (a) indirect assessments based on the ...
  10. TSRC, Tob. Sci. Res. Conf., 2018, 72, abstr. 039 (also presented at CORESTA 2018)

    Consumers’ perceptions of disease-specific modified-risk claims are best evaluated in a disease-specific manner

    SHIFFMAN S.(1); CURTIN G.M.(2)
    (1) PinneyAssociates, Pittsburgh, PA, USA; (2) RAI Services Company, Winston-Salem, NC, USA
    Manufacturers seeking to make claims about modified-risk tobacco products (MRTPs) must assess consumers' perceptions of risk reduction for that product. Claims made for the MRTP and assessment of perceived risk reduction can be global (e.g., &quot ...